Trials / Sponsors / TORL Biotherapeutics, LLC
TORL Biotherapeutics, LLC
Industry · 8 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | 2026-01-30 |
| Recruiting | CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial FIGO Stage III and IV Ovarian Cancer, Fallopian Tube Cancers, Primary Peritoneal Cancer | Phase 1 / Phase 2 | 2025-12-10 |
| Recruiting | CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. Epithelial Ovarian Cancer, Primary Peritoneal, Fallopian Tube Cancer | Phase 2 | 2024-11-20 |
| Recruiting | A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer Advanced Solid Tumor, Hepatocellular Carcinoma | Phase 1 | 2023-12-04 |
| Active Not Recruiting | First in Human Study of TORL-3-600 in Participants With Advanced Cancer Advanced Solid Tumor, Colorectal Cancer | Phase 1 | 2023-09-29 |
| Active Not Recruiting | First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer Advanced Solid Tumor, Gastric Cancer, Pancreas Cancer | Phase 1 | 2022-02-02 |
| Active Not Recruiting | First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer Advanced Solid Tumor, Gastric Cancer, Pancreas Cancer | Phase 1 | 2022-01-20 |
| Recruiting | First in Human Study of TORL-1-23 in Participants With Advanced Cancer Advanced Solid Tumor, Ovarian Cancer, Endometrial Cancer | Phase 1 | 2021-11-17 |